Cleared Traditional

K213081 - CLISIS SYSTEMS, Discovery RF180 (FDA 510(k) Clearance)

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K213081 · General Medical Merate S.P.A · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2021
Decision
33d
Days
Class 2
Risk

K213081 is an FDA 510(k) clearance for the CLISIS SYSTEMS, Discovery RF180. Classified as System, X-ray, Tomographic (product code IZF), Class II - Special Controls.

Submitted by General Medical Merate S.P.A (Seriate, IT). The FDA issued a Cleared decision on October 26, 2021 after a review of 33 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1740 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all General Medical Merate S.P.A devices

Submission Details

510(k) Number K213081 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 23, 2021
Decision Date October 26, 2021
Days to Decision 33 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
74d faster than avg
Panel avg: 107d · This submission: 33d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IZF System, X-ray, Tomographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1740
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

THEMA S.r.l.
Marisa Testa

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - IZF System, X-ray, Tomographic

All 41
Devices cleared under the same product code (IZF) and FDA review panel - the closest regulatory comparables to K213081.
TAP2D
K252649 · Nano-X Imaging , Ltd. · Feb 2026
Adaptix Ortho350
K252133 · Adaptix Limited · Nov 2025
Nanox.ARC X
K250850 · Nano-X Imaging , Ltd. · Apr 2025
Nanox.ARC
K242395 · Nano-X Imaging , Ltd. · Dec 2024
Nanox.ARC
K222934 · Nano-X Imaging , Ltd. · Apr 2023
Ortho Device, ADAPTIX 3D Orthopedic Imaging System
K221949 · Pausch Medical GmbH · Jan 2023